Advertisement

Topics

DMD gene therapy start-up Exonics launches with seed round from CureDuchenne Ventures

14:40 EST 9 Nov 2017 | Elsevier Business Intelligence

Recently formed Exonics Therapeutics Inc. (CRISPR/Cas9 gene editing technologies for Duchenne muscular dystrophy (DMD)) raise...

Original Article: DMD gene therapy start-up Exonics launches with seed round from CureDuchenne Ventures

NEXT ARTICLE

More From BioPortfolio on "DMD gene therapy start-up Exonics launches with seed round from CureDuchenne Ventures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...